Reference |
3718
Shoda J1, Matsuda A2, Shida T3, Yamamoto M, Nagino M, Tsuyuguchi T, Yasaka T, Tazuma S, Uchiyama K, Unno M, Ohkohchi N, Nakanuma Y, Kuno A, Narimatsu H.
Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
J Gastroenterol
2017
52(2):218-228
PubMed ID: 27358229
DOI: 10.1007/s00535-016-1230-0
|
3704
Seto 1, Shoda J, Horibe T, Warabi E, Kohno M, Yanagawa T, Bukawa H, Nakanuma Y, Kawakami K.
Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.
Int J Hepatol
2014
584650
PubMed ID: 24868471
DOI: 10.1155/2014/584650
|
3716
Onuki K1, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S, Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.
Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
J Gastroenterol
2014
49(4):702-14
PubMed ID: 23588887
DOI: 10.1007/s00535-013-0813-2
|
2323
Kawashima R, Abei M, Fukuda K, Nakamura K, Murata T, Wakayama M, Seo E, Hasegawa N, Mizuguchi H, Obata Y, Hyodo I, Hamada H, Yokoyama KK.
EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus
Int J Cancer
2011
129(5):1244-53
PubMed ID: 21710497
DOI: 10.1002/ijc.25758
|
3708
Ishige K, Shoda J, Kawamoto T, Matsuda S, Ueda T, Hyodo I, Ohkohchi N, Puri RK, Kawakami K.
Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.
Int J Cancer
2008
123(12):2915-22
PubMed ID: 18798553
DOI: 10.1002/ijc.23865
|
2324
Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H, Murata T, Tanaka N, Hyodo I, Hamada H, Yokoyama KK.
E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers
Clin Cancer Res
2007
13(10):3043-50
PubMed ID: 17505007
DOI: 10.1158/1078-0432.CCR-06-2103
|
2321
Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y.
Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis
Oncology
2006
71(1-2):102-10
PubMed ID: 17341890
DOI: 10.1159/000100478
|
2673
Ghosh, Mila, Koike, Naoto, Yanagimoto, Go, Tsunoda, Shin-Ichi, Kaul, Sunil, Hirano, Takashi, Emura, Fabian, Kashiwagi, Hironobu, Kawamoto, Toru, Ohkohchi, Nobuhiro, Saijo, Kaoru, Ohno, Tadao, Miwa, Masanao, Todoroki, Takeshi
Establishment and characterization of unique human gallbladder cancer cell lines.
Int J Oncol
2004
24:1189-96
PubMed ID: 15067341
|
3707
Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.
Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
Clin Cancer Res
2004
10(6):2090-9
PubMed ID: 15041730
DOI: 10.1158/1078-0432.ccr-1024-03
|
2322
Shoda J, Ueda T, Kawamoto T, Todoroki T, Asano T, Sugimoto Y, Ichikawa A, Maruyama T, Nimura Y, Tanaka N.
Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis
Clin Gastroenterol Hepatol
2003
1(4):285-96
PubMed ID: 15017670
|
2319
Koike N, Todoroki T, Kawamoto T, Yoshida S, Kashiwagi H, Fukao K, Ohno T, Watanabe T
The invasion potentials of human biliary tract carcinoma cell lines: correlation between invasiveness and morphologic characteristics.
Int J Oncol
1998
13:1269-74
PubMed ID: 9824643
DOI: 10.3892/ijo.13.6.1269
|
User's Publication |
19816
J V, Palo A, Besra K, Dixit M.
Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites
Hum Mol Genet
2023
32(14):2357-2372
PubMed ID: 37162337
DOI: 10.1093/hmg/ddad077
|
19960
Nakano M, Sakamoto T, Kitano Y, Bono H, Simpson RJ, Tabunoki H.
An extract from the frass of swallowtail butterfly (Papilio machaon) larvae inhibits HCT116 colon cancer cell proliferation but not other cancer cell types
BMC Genomics
2023
24(1):735
PubMed ID: 38049715
DOI: 10.1186/s12864-023-09841-0
|
15892
Khorsandi SE, Dokal AD, Rajeeve V, Britton DJ, Illingworth MS, Heaton N, Cutillas PR.
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets.
Cancer Res
2021
81(22):5765-5776
PubMed ID: 34551960
DOI: 10.1158/0008-5472.CAN-21-0955
|
12106
García P, Rosa L, Vargas S, Weber H, Espinoza JA, Suárez F, Romero-Calvo I, Elgueta N, Rivera V, Nervi B, Obreque J, Leal P, Viñuela E, Aguayo G, Muñiz S, Sagredo A, Roa JC, Bizama C.
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
Cancers (Basel)
2020
PubMed ID: 32218280
DOI: 10.3390/cancers12040778
|
12131
García P, Bizama C, Rosa L, Espinoza JA, Weber H, Cerda-Infante J, Sánchez M, Montecinos VP, Lorenzo-Bermejo J, Boekstegers F, Dávila-López M, Alfaro F, Leiva-Acevedo C, Parra Z, Romero D, Kato S, Leal P, Lagos M, Roa JC.
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
Biol. Res.
2020
PubMed ID: 32293552
DOI: 10.1186/s40659-020-00282-7
|
20122
Hendaoui I, Lahmar A, Campo L, Mebarki S, Bichet S, Hess D, Degen M, Kchir N, Charrada-Ben Farhat L, Hefaiedh R, Ruiz C, Terracciano LM, Tucker RP, Hendaoui L, Chiquet-Ehrismann R.
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.
Front Immunol
2020
11:630139
PubMed ID: 33692777
DOI: 10.3389/fimmu.2020.630139
|
3721
Li L, Knutsdottir H, Hui K, Weiss MJ, He J, Philosophe B, Cameron AM, Wolfgang CL, Pawlik TM, Ghiaur G, Ewald AJ, Mezey E, Bader JS, Selaru FM.
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity.
JCI Insight
2019
4(2):e121490.
PubMed ID: 30674722
DOI: 10.1172/jci.insight.121490
|
3724
Zhou F, Zhang Y, Sun J, Yang X.
Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma.
Cancer Cell Int
2019
19:190
PubMed ID: 31367188
DOI: 10.1186/s12935-019-0911-1
|
10170
Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Oncotarget
2017
8:26169-26184
PubMed ID: 28412732
DOI: 10.18632/oncotarget.15410
|
10222
Yang L, Huang S, Ma H, Wu X, Feng F.
MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.
Tumour Biol.
2017
39:1010428317692249
PubMed ID: 28347246
DOI: 10.1177/1010428317692249
|
3690
uchegger K, Silva R2, López J1, Ili C1, Araya JC3, Leal P2, Brebi P1, Riquelme I4, Roa JC5.
The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Pathol Res Pract.
2017
213(5):476-482
PubMed ID: 28285962
DOI: 10.1016/j.prp.2017.01.025
|
3720
Tamaki N, Kuno A, Matsuda A, Tsujikawa H, Yamazaki K, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Korenaga M, Mizokami M, Kurosaki M, Sakamoto M, Narimatsu H, Izumi N5.
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.
Sci Rep
2017
7(1):244
PubMed ID: 28325920
DOI: 10.1038/s41598-017-00357-8
|
3723
Liu ZY, Xu GL, Tao HH, Yang YQ, Fan YZ.
Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.
Cancer Cell Int
2017
17:20
PubMed ID: 28194091
DOI: 10.1186/s12935-017-0388-8
|
7134
Mohri D, Ijichi H, Miyabayashi K, Takahashi R, Kudo Y, Sasaki T, Asaoka Y, Tanaka Y, Ikenoue T, Tateishi K, Tada M, Isayama H, Koike K.
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
J. Gastroenterol.
2016
51:711-21
PubMed ID: 26614007
DOI: 10.1007/s00535-015-1145-1
|
3710
Yamaguchi T, Yokoyama Y, Ebata T, Matsuda A, Kuno A, Ikehara Y, Shoda J, Narimatsu H, Nagino M.
Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
Ann Surg Oncol
2016
23(2):671-7
PubMed ID: 26416714
DOI: 10.1245/s10434-015-4878-4
|
12665
Cavalloni G, Peraldo-Neia C, Varamo C, Chiorino G, Sassi F, Aglietta M, Leone F.
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
Oncotarget
2016
7(32):52354-52363
PubMed ID: 27429047
DOI: 10.18632/oncotarget.10587
|
7273
Nakano T, Saiki Y, Kudo C, Hirayama A, Mizuguchi Y, Fujiwara S, Soga T, Sunamura M, Matsumura N, Motoi F, Unno M, Horii A.
Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK.
Biochem. Biophys. Res. Commun.
2015
464:1084-9
PubMed ID: 26196746
DOI: 10.1016/j.bbrc.2015.07.080
|
7355
Saeki N, Ono H, Sakamoto H, Yoshida T.
Down-regulation of Immune-related Genes by PSCA in Gallbladder Cancer Cells Implanted into Mice.
Anticancer Res.
2015
35:2619-25
PubMed ID: 25964537
|
7466
Saeki N, Ono H, Yanagihara K, Aoyagi K, Sasaki H, Sakamoto H, Yoshida T.
rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1.
Genes Cells
2015
20:382-91
PubMed ID: 25727947
DOI: 10.1111/gtc.12228
|
3706
Matsuda A, Kuno A, Nakagawa T, Ikehara Y, Irimura T, Yamamoto M, Nakanuma Y, Miyoshi E, Nakamori S, Nakanishi H, Viwatthanasittiphong C, Srivatanakul P, Miwa M, Shoda J, Narimatsu H.
Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.
Anal Chem
2015
87(14):7274-81
PubMed ID: 26091356
DOI: 10.1021/acs.analchem.5b01329
|
3709
Kawamoto T, Ishige K, Thomas M, Yamashita-Kashima Y, Shu S, Ishikura N, Ariizumi S, Yamamoto M, Kurosaki K, Shoda J.
Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
J Gastroenterol
2015
50(4):467-79
PubMed ID: 25112701
DOI: 10.1007/s00535-014-0984-5
|
17464
Shi Z, Huang Q, Chen J, Yu P, Wang X, Qiu H, Chen Y, Dong Y.
Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder
Am J Transl Res
2015
7(10):2015-25
PubMed ID: 26692945
|
4891
Peraldo Neia C, Cavalloni G, Balsamo A, Venesio T, Napoli F, Sassi F, Martin V, Frattini M, Aglietta M, Leone F.
Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR.
Genes Chromosomes Cancer
2014
53(12):1033-40
PubMed ID: 25231053
DOI: 10.1002/gcc.22212
|
13739
Letelier P, García P, Leal P, Álvarez H, Ili C, López J, Castillo J, Brebi P, Roa JC.
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer
Int J Clin Exp Pathol
2014
7(5):1849-67
PubMed ID: 24966896
|
3694
Yang S, Lee KT, Lee JY, Lee JK, Lee KH, Rhee JC.
Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.
Tumour Biol
2013
34(5):2731-9
PubMed ID: 23653380
DOI: 10.1007/s13277-013-0825-9
|
3695
Ono H, Chihara D, Chiwaki F, Yanagihara K, Sasaki H, Sakamoto H, Tanaka H, Yoshida T, Saeki N, Matsuo K.
Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells.
J Carcinog
2013
12:4
PubMed ID: 23599686
DOI: 10.4103/1477-3163.109030
|
3714
Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.
Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
World J Gastroenterol
2013
19(11):1718-27
PubMed ID: 23555160
DOI: 10.3748/wjg.v19.i11.1718
|
3715
Idrees AS, Sugie T, Inoue C, Murata-Hirai K, Okamura H, Morita CT, Minato N, Toi M, Tanaka Y.
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Cancer Sci
2013
104(5):536-42
PubMed ID: 23387443
DOI: 10.1111/cas.12124
|
3722
Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H, Arimura Y, Imai K, Carbone DP, Shinomura Y.
Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
Cancer Sci
2012
103(2):252-61
PubMed ID: 22044563
DOI: 10.1111/j.1349-7006.2011.02138.x
|
6101
Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ, Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, Chiwaki F, Sasaki H, Sakamoto H, Yoshida T, Saeki N.
Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
Genes Chromosomes Cancer.
2012
51(1):30-41
PubMed ID: 21936014
DOI: 10.1002/gcc.20928
|
6319
Wu LC, Chen LT, Tsai YJ, Lin CM, Lin CY, Tian YF, Sheu MJ, Uen YH, Shiue YL, Wang YH, Yang SJ, Wu WR, Li SH, Iwamuro M, Kobayasshi N, Huang HY, Li CF.
Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
J Clin Pathol
2012
65(4):309-14
PubMed ID: 22267983
DOI: 10.1136/jclinpath-2011-200489
|
16078
Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, Rhee JC.
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB
J Cancer Res Clin Oncol
2012
138(10):1743-51
PubMed ID: 22699931
DOI: 10.1007/s00432-012-1254-7
|
7862
Sato J, Kimura T, Saito T, Anazawa T, Kenjo A, Sato Y, Tsuchiya T, Gotoh M.
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
J Hepatobiliary Pancreat Sci
2011
18:700-11
PubMed ID: 21451941
DOI: 10.1007/s00534-011-0376-7
|
8068
Takeuchi T, Adachi Y, Nagayama T, Furihata M.
Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.
Int J Exp Pathol
2011
92:79-86
PubMed ID: 21039987
DOI: 10.1111/j.1365-2613.2010.00740.x
|
3711
Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H.
Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.
Cancer Sci
2011
102(2):407-13
PubMed ID: 21166957
DOI: 10.1111/j.1349-7006.2010.01808.x
|
3702
Tan FL, Ooi A, Huang D, Wong JC, Qian CN, Chao C, Ooi L, Tan YM, Chung A, Cheow PC, Zhang Z, Petillo D, Yang XJ, Teh BT.
p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
Int J Cancer
2010
126(10):2353-61
PubMed ID: 19816939
DOI: 10.1002/ijc.24944
|
3705
Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki K, Taniguchi H, Adachi Y, Imai K, Shinomura Y.
Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.
World J Gastroenterol
2009
15(31):3865-73
PubMed ID: 19701966
DOI: 10.3748/wjg.15.3865
|
3719
van Haaften G et al
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
Nat Genet
2009
41(5):521-3
PubMed ID: 19330029
DOI: 10.1038/ng.349
|
3712
Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S, Itoh F.
Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer.
World J Gastroenterol
2008
14(17):2702-14
PubMed ID: 18461655
DOI: 10.3748/wjg.14.2702
|
3700
Wu XS, Akiyama Y, Igari T, Kawamura T, Hiranuma S, Shibata T, Tsuruta K, Koike M, Arii S, Yuasa Y.
Expression of homeodomain protein CDX2 in gallbladder carcinomas.
J Cancer Res Clin Oncol
2005
131(5):271-8
PubMed ID: 15645288
DOI: 10.1007/s00432-004-0658-4
|
3701
DINGAng TONGSaixiong SUOTao
Relations of hTERT and β-Catenin Expression with Cell Growth and Invasion in Gallbladder Cell Line
Clinical Medical Journal of China
2005
|
3713
Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Oncogene
2005
24(53):7946-52
PubMed ID: 16007117
DOI: 10.1038/sj.onc.1208910
|
3703
Sanada T, Yokoi S, Arii S, Yasui K, Imoto I, Inazawa J.
Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers.
Cancer Sci
2004
95(12):969-76
PubMed ID: 15596046
DOI: 10.1111/j.1349-7006.2004.tb03185.x
|
3717
Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T.
Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Oncogene
2004
23(13):2401-7
PubMed ID: 14743205
DOI: 10.1038/sj.onc.1207395
|
3696
Hirata K, Takada M, Suzuki Y, Kuroda Y.
Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
Hepatogastroenterology
2003
50(53):1205-7
PubMed ID: 14571699
|
3699
Nakano K, Todo T, Chijiiwa K, Tanaka M.
Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
Mol Ther
2001
3(4):431-7.
PubMed ID: 11319903
DOI: 10.1006/mthe.2001.0303
|